Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
82% of industry CEOs concerned about FDA's abilities: survey
Biotech CEOs worry that added volatility in an already high-risk industry will discourage investment or will drive it to other countries.
Gabrielle Masson
Nov 21, 2025 4:38pm
CDC orders researchers to end all monkey studies: Science
Nov 21, 2025 1:15pm
FDA unveils hiring spree, new comms program to speed reviews
Nov 21, 2025 11:43am
Moderna winds down 3 mRNA programs
Nov 20, 2025 4:10pm
Roche inks $200M pact for Freenome's cancer screening blood test
Nov 21, 2025 10:55am
Fierce Pharma
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am
More News
Gilead abruptly parts ways with general counsel—Chutes & Ladders
Nov 21, 2025 8:30am
Fierce Biotech Layoff Tracker 2025: Ensoma, Applied Tx & more
Nov 21, 2025 7:00am
Nurix trims staff as trial for lead BTK degrader kicks off
Nov 21, 2025 5:05am
Contineum-J&J drug fails to improve vision in phase 2 MS trial
Nov 20, 2025 5:26pm
See more stories